Waller, Claire R.
Pandey, Mallika
Boggs, Jennifer M.
Beck, Arne
Bedoy, Ruth P.
Buttenheim, Alison M.
Elias, Marisa E.
Hoskins, Katelin
Jager-Hyman, Shari
Johnson, Christina
Maye, Melissa
McArdle, Bridget
Pappas, Celeste
Small, Dylan S.
Quintana, LeeAnn M.
Benjamin Wolk, Courtney
Wright, Leslie A.
Williams, Nathaniel J.
Ahmedani, Brian K.
Beidas, Rinad S.
Funding for this research was provided by:
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
National Institute of Mental Health (R01MH123491)
Article History
Received: 22 August 2025
Accepted: 7 May 2026
First Online: 20 May 2026
Declarations
:
: The ASPIRE trial was approved by the University of Pennsylvania institutional review board (IRB; protocol #844327). In compliance with the National Institutes of Health, all participating health systems agreed to rely on a single IRB (sIRB); the University of Pennsylvania IRB is the designated sIRB. Reliance agreements were completed by all participating sites. Informed consent was obtained from all participating HCWs for qualitative interviews.
: Not applicable.
: Dr. Beidas receives funding from the NIH, Northwestern Medicine, National Psoriasis Foundation, American Foundation for Suicide Prevention, West Health Institute, Sanofi, and Pfizer for her research. Dr. Beidas is principal at Implementation Science & Practice, LLC and serves as co-Editor-In-Chief for Implementation Science. She is currently an appointed member of the National Advisory Mental Health Council and serves on the scientific advisory board for AIM Youth Mental Health Foundation, Klingenstein Third Generation Foundation, and the American Foundation for Suicide Prevention. She was previously an appointed member of the NASEM study, “Blueprint for a national prevention infrastructure for behavioral health disorders,” served on the scientific and advisory board for Optum Behavioral Health, received consulting fees from United Behavioral Health and OptumLabs, and received royalties from Oxford University Press. All activities are outside of the submitted work. Christina Johnson, MPH receives project funding from the NIH, Sanofi, Northwestern Medicine, and the National Psoriasis Foundation. Dr. Benjamin Wolk receives royalties from Oxford University Press for a textbook on children’s mental health; consulting fees from Massachusetts General Hospital (implementation science consultation); and funding unrelated to the present project from the National Institute for Mental Health and Agency for Healthcare Research and Quality outside the submitted work. Dr. Williams provided research consultancy with the US National Institutes of Health during the conduct of the study. No other disclosures were reported.